Product Information
COLESTIPOL HCL 1 GM TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.6579 per EA under NDC 62559039512. Its NADAC has been published 162 times since Aug 30, 2023.
FDA first approved this application on Mar 10, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559039512
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
COLESTIPOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216517FDA Approved
3/10/2023
TE Code
AB
On Market Since
5/15/2023
Pharmacological Classes
Price Statistics
The NADAC for COLESTIPOL HCL 1 GM TABLET has been published 162 times since Aug 30, 2023, and over the history we have for it it has declined 20.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6579 per EA |
|---|---|
| All-time high | $0.8463 (Oct 11, 2023) |
| All-time low | $0.5635 (Nov 20, 2024) |
| 52-week high | $0.6835 |
| 52-week low | $0.6534 |
| Median price | $0.6839 |
| Average price | $0.7084 |
| Largest weekly change | -24.6% (Nov 20, 2024) |
| Weeks tracked | 162 |
| Tracking since | Aug 30, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
COLESTIPOL HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid Sequestrant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLESTIPOL HCL 1 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLESTIPOL HCL 1 GM TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.6579 per EA (NDC 62559039512), effective Sep 30, 2026.
How has the price of COLESTIPOL HCL 1 GM TABLET changed over time?
Over the history we have for it, the NADAC for COLESTIPOL HCL 1 GM TABLET has declined 20.8%. It has been tracked across 162 weekly CMS publications since Aug 30, 2023.
What are the highest and lowest recorded NADAC prices for COLESTIPOL HCL 1 GM TABLET?
Since Aug 30, 2023, the NADAC for COLESTIPOL HCL 1 GM TABLET has ranged from a low of $0.5635 (Nov 20, 2024) to a high of $0.8463 (Oct 11, 2023), with a median of $0.6839 per EA.
Are there cheaper alternatives to COLESTIPOL HCL 1 GM TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as COLESTIPOL HCL 1 GM TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures COLESTIPOL HCL 1 GM TABLET?
COLESTIPOL HCL 1 GM TABLET (NDC 62559039512) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.